Pharmacoeconomics and Quality of Life Research Beyond the Randomized Clinical Trial

Published in: Quality of Life and Pharmacoeconomics in Clinical Trials, 2d Ed. Edited by B. Spilker (Philadelphia: Lippincott-Raven Publishers, 1996), Chapter 18, p. 155-159

Posted on on January 01, 1996

by Ron D. Hays, Cathy D. Sherbourne, Samuel A. Bozzette

Read More

Access further information on this document at

This article was published outside of RAND. The full text of the article can be found at the link above.

Randomized clinical trials (RCTs) yield essential information about potential therapeutic interventions when the optimal treatment for a condition is unknown. They provide a basis for a causal inference about the effects of medication on quality of life by virtue of their experimental design. The authors discuss the various ways that the emphasis of effectiveness research studies, which observes what takes place under existing circumstances, differ from that of a typical RCT, with particular focus on selection of participants, assessment of study variables, and analyses of outcomes data.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.